Indaptus Therapeutics (INDP) Earnings Analysis

Indaptus Therapeutics (INDP) next reports earnings on 2026-08-17, consensus EPS -1.57 USD. Last quarter (2026-05-15) it beat with EPS -0.23 USD vs -1.87 USD est (+87.7%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -0.42.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does INDP next report earnings?

Next earnings date2026-08-17
Consensus EPS estimate-1.57 USD
Revenue estimaten/a

INDP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.23 USD-1.87 USD+87.7%Beat
2026-03-17-3.1 USD-4.36 USD+28.9%Beat
2025-11-12-2.98 USD-4.17 USD+28.5%Beat
2025-08-13-9.09 USD-9.24 USD+1.6%Beat
2025-03-13-0.38 USD-0.41 USD+7.3%Beat
2024-08-12-0.47 USD-0.54 USD+13%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

INDP valuation and analyst view

Trailing P/E-0.42
Trailing EPS-8.70085 USD
Price / book4.59
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Indaptus Therapeutics (INDP)'s next earnings date?

Indaptus Therapeutics is next scheduled to report on 2026-08-17, with a consensus EPS estimate of -1.57 USD.

Did INDP beat earnings last quarter?

In its 2026-05-15 report, INDP posted EPS of -0.23 USD versus a -1.87 USD estimate — a beat of 87.7%.

What is INDP's earnings track record?

Over the last 6 reported quarters with consensus data, INDP beat estimates 6 times (100%).

What is INDP's current P/E ratio and EPS?

INDP trades at a trailing P/E of -0.42 on trailing EPS of -8.700847681288076 USD.

What do analysts rate INDP?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).